North America Cell Therapy Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Therapy Type (Allogeneic and Autologous), Product (Consumables, Equipment, and Systems and Software), Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, and Three-Dimensional Technology), Application (Oncology, Cardiovascular, Orthopedic, Wound Management, and Other Applications), and End User (Research Institutes, Hospitals, and Others), and Country


No. of Pages: 158    |    Report Code: TIPRE00018850    |    Category: Life Sciences

North America Cell Therapy Market
Buy Now

Market Introduction

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.


Get more information on this report

North America Cell Therapy Strategic Insights

Strategic insights for the North America Cell Therapy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-cell-therapy-market-strategic-framework.webp
Get more information on this report

North America Cell Therapy Report Scope

Report Attribute Details
Market size in 2019 US$ 291.39 Million
Market Size by 2027 US$ 1,406.47 Million
Global CAGR (2020 - 2027) 7.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Therapy Type
  • Allogeneic and Autologous
By Product
  • Consumables
  • Equipment
  • Systems and Software
By Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology
By Application
  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Applications
By End User
  • Research Institutes
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.
  • Get more information on this report

    North America Cell Therapy Regional Insights

    The geographic scope of the North America Cell Therapy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/north-america-cell-therapy-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The North America cell therapy market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 7.4% from 2020 to 2027. Factors driving the market growth include growing collaborative efforts to promote cell therapy, and developments in cell therapy against COVID–19. However, stringent regulations is likely to restraint the market growth during the forecast period.

    Key Market Segments

    In terms of therapy type, in 2019, the allogeneic, and autologous. The allogeneic segment held the largest share of the market in 2019. The growth of segment is expected due to increasing focus on the development of regenerative therapies by increasingly emphasizing innovations and manufacturing. In addition, the availability of substantial number of approved products for clinical use is likely to continue the growth of segment during the forecast period. However, the autologous segment is anticipated to register the highest CAGR in the market during the forecast period.

    Major Sources and Companies Listed

    World Health Organization, Food and Drug Administration, and American Society of Gene & Cell Therapy, and Stem Cell Network are some of the major primary and secondary sources for the North America cell therapy market included in the report.

    Reasons to buy the report

    • To understand the North America cell therapy market landscape and identify market segments that are most likely to guarantee a strong return
    • To stay ahead of the race by comprehending the ever-changing competitive landscape for the North America cell therapy market
    • To efficiently plan M&A and partnership deals in the North America cell therapy market by identifying market segments with the most promising probable sales
    • To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of the North America cell therapy market
    • To obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

    North America

    Cell Therapy Market Segmentation

    By Therapy Type

    • Allogeneic
    • Autologous

    By Product

    • Consumables
    • Equipment
    • Systems and Software

    By Technology

    • Viral Vector Technology
    • Genome Editing Technology
    • Somatic Cell Technology
    • Cell Immortalization Technology
    • Cell Plasticity Technology
    • Three-Dimensional Technology

    By Application

    • Oncology
    • Cardiovascular
    • Orthopedic
    • Wound Management
    • Other Applications

    By End User

    • Research Institutes
    • Hospitals
    • Others

     

    Company Profiles

    • Vericel Corporation
    • MEDIPOST
    • NuVasive, Inc
    • Mesoblast Limited
    • Smith & Nephew
    • Bristol-Myers Squibb Company
    • Stemedica Cell Technologies, Inc
    • Castle Creek Biosciences, Inc.

    The List of Companies - North America Cell Therapy Market

    Company Profiles
    1. Vericel Corporation
    2. MEDIPOST
    3. NuVasive, Inc
    4. Mesoblast Limited
    5. Smith & Nephew
    6. Bristol-Myers Squibb Company
    7. Stemedica Cell Technologies, Inc
    8. Castle Creek Biosciences, Inc.
    Frequently Asked Questions
    How big is the North America Cell Therapy Market?

    The North America Cell Therapy Market is valued at US$ 291.39 Million in 2019, it is projected to reach US$ 1,406.47 Million by 2027.

    What is the CAGR for North America Cell Therapy Market by (2020 - 2027)?

    As per our report North America Cell Therapy Market, the market size is valued at US$ 291.39 Million in 2019, projecting it to reach US$ 1,406.47 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.

    What segments are covered in this report?

    The North America Cell Therapy Market report typically cover these key segments-

    • Therapy Type (Allogeneic and Autologous)
    • Product (Consumables, Equipment, Systems and Software)
    • Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-Dimensional Technology)
    • Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications)
    • End User (Research Institutes, Hospitals)

    What is the historic period, base year, and forecast period taken for North America Cell Therapy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cell Therapy Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Cell Therapy Market?

    The North America Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.
  • Who should buy this report?

    The North America Cell Therapy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now